News|Articles|October 23, 2018

Eye Solution Recalled

Promise Pharmacy recalls one lot of Prednisolone and Gatifloxacin Ophthalmic Solution 1%/0.5% sterile, 3mL vials due to particulates in the solution.

Promise Pharmacy announced on Oct. 22, 2018 that it was voluntarily recalling one lot of Prednisolone and Gatifloxacin Ophthalmic Solution 1%/0.5% sterile, 3mL vials to the consumer level. The recall is in response to unidentified small particulates that were found floating in the solution. The affected lot number is 09042018@2 with an expiration of 12/03/2018 and was distributed nationwide.

The product is used as a post-surgical (cataract) ophthalmic treatment. While the company has not received reports of adverse events, it says that use of contaminated product could result in limited eye irritation, inflammation, visual impairment, or permanent ocular damage.

The company stated in a press release that patients should stop using the product and return it to the company. Adverse events may be reported to FDA through its MedWatch program.

Source: FDA

 


Related to this article

Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.